# A Study to Determine the Safety and Efficacy of NT-501 With MHFM

> **NCT06397131** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Neurotech Pharmaceuticals** · enrollment: 12 (actual)

## Conditions studied

- Macular Telangiectasia Type 2

## Interventions

- **COMBINATION_PRODUCT:** NT-501 CNTF Implant

## Key facts

- **NCT ID:** NCT06397131
- **Lead sponsor:** Neurotech Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-06
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-07-24
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06397131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06397131, "A Study to Determine the Safety and Efficacy of NT-501 With MHFM". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06397131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*